2014
An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation
Chaloupka FJ, Warner KE, Acemoğlu D, Gruber J, Laux F, Max W, Newhouse J, Schelling T, Sindelar J. An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation. Tobacco Control 2014, 24: 112. PMID: 25550419, PMCID: PMC4345832, DOI: 10.1136/tobaccocontrol-2014-052022.Peer-Reviewed Original ResearchConceptsEconomic impact analysisSound economic analysisNet economic benefitsImpact analysisProminent economistsSignificant regulatory actionsEconomic analysisDrug Administration's regulatory authorityNet benefitEconomic benefitsTobacco productsGraphic warning labelsRegulatory authoritiesLabel regulationsCostTobacco product regulationRegulatory actionProduct regulationEconomistsAuthoritiesBenefitsFuture analysesRulesControl ActJurisdictions
2010
Human and environmental health challenges for the next decade (2010–2020)
Bonnefoi M, Belanger S, Devlin D, Doerrer N, Embry M, Fukushima S, Harpur E, Hines R, Holsapple M, Kim J, MacDonald J, O’Lone R, Pettit S, Stevens J, Takei A, Tinkle S, van der Laan J. Human and environmental health challenges for the next decade (2010–2020). Critical Reviews In Toxicology 2010, 40: 893-911. PMID: 20854192, DOI: 10.3109/10408444.2010.506640.Peer-Reviewed Original ResearchConceptsKey governmentEnvironmental health challengesGovernment agenciesMapping exerciseScientific portfolioNext decadeResearch institutionsRegulatory challengesFuture landscapeEnvironmental communityIndividual companiesKey challengesRegulatory authoritiesPublic healthHealth challengesSignificant issue
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply